Get started
Author

Weiqi Nian

Observed names: W. Nian, W.Q. Nian, WEIQI NIAN, Wei-Qi Nian, Wei-qi Nian
Observed institutions: Army Medical University, Chongqing University, Xinqiao Hospital, Chongqing Cancer Hospital, Chongqing Municipal Health Commission, The University of Texas Health Science Center at Houston
ORCID: 0000-0001-6596-9443
Observed ORCID: 0000-0001-6596-9443
OpenAlex ID: A5002345896
Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies
2023 · Q. Gao, Y.P. Lin, et al. · Annals of Oncology · 130
PDF
ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway
2021 · Xiaoyuan Lin, Beibei Fu, et al. · iScience · 128
PDF
Evaluation of Safety of Treatment With Anti–Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors
2022 · Miao-Zhen Qiu, Yang Zhang, et al. · JAMA Oncology · 84
PDF
Lipin‐1 regulation of phospholipid synthesis maintains endoplasmic reticulum homeostasis and is critical for triple‐negative breast cancer cell survival
2017 · Jingquan He, Feng Zhang, et al. · The FASEB Journal · 73
Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma
2022 · Biyuan Luo, Fang Ma, et al. · BMC Medicine · 69
PDF
MicroRNA-325-3p Facilitates Immune Escape of Mycobacterium tuberculosis through Targeting LNX1 via NEK6 Accumulation to Promote Anti-Apoptotic STAT3 Signaling
2020 · Beibei Fu, Weiwei Xue, et al. · mBio · 63
Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer
2022 · Leilei Liang, Yu Zhang, et al. · EBioMedicine · 61
miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2
2013 · WEIQI NIAN, XUJUN AO, et al. · Oncology Letters · 60
PDF
Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study
2021 · Guibin Qiao, Weitao Zhuang, et al. · BMC Medicine · 59
PDF
A regulatory loop involving miR-29c and Sp1 elevates the TGF-β1 mediated epithelial-to-mesenchymal transition in lung cancer
2016 · Hai-wei Zhang, En-wen Wang, et al. · Oncotarget · 49
PDF
Ribosome Proteins Represented by RPL27A Mark the Development and Metastasis of Triple-Negative Breast Cancer in Mouse and Human
2021 · Weipeng Zhao, Xichuan Li, et al. · Frontiers in Cell and Developmental Biology · 40
PDF
Preliminary safety and efficacy results from phase 1 studies of DZD9008 in NSCLC patients with EGFR Exon20 insertion mutations.
2021 · James Chih-Hsin Yang, Mengzhao Wang, et al. · Journal of Clinical Oncology · 38
MiR-342 controls Mycobacterium tuberculosis susceptibility by modulating inflammation and cell death
2021 · Beibei Fu, Xiaoyuan Lin, et al. · EMBO Reports · 36
PDF
Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study
2021 · Jinke Sui, Xianrui Wu, et al. · Clinical Epigenetics · 35
PDF
CXCR4 positive cells from Lewis lung carcinoma cell line have cancer metastatic stem cell characteristics
2011 · Wei-Qi Nian, Fang-Lin Chen, et al. · Molecular and Cellular Biochemistry · 33
Sensitivity of non-small cell lung cancer to erlotinib is regulated by the Notch/miR-223/FBXW7pathway
2017 · Haiwei Zhang, Fanglin Chen, et al. · Bioscience Reports · 32
PDF
Long non-coding RNA LSINCT5 promotes ovarian cancer cell proliferation, migration and invasion by disrupting the CXCL12/CXCR4 signalling axis
2018 · Xingtao Long, Li Li, et al. · Oncology Letters · 31
PDF
HE4 as a biomarker for diagnosis of lung cancer
2019 · Yong-Peng He, Li-Xian Li, et al. · Medicine · 27
Heme oxygenase 1 facilitates cell proliferation via the B-Raf-ERK signaling pathway in melanoma
2019 · Liu Liu, Yan Wu, et al. · Cell Communication and Signaling · 26
PDF
High-efficiency detection of APE1 using a defective PAM-driven CRISPR-Cas12a self-catalytic biosensor
2025 · Yang Song, Long Juan, et al. · Biosensors and Bioelectronics · 22
Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation
2025 · Jingwen Liu, Jia Jiang, et al. · Journal of Experimental & Clinical Cancer Research · 21
PDF
Updated Efficacy and Safety Results of Lisaftoclax (APG-2575) in Patients (Pts) with Heavily Pretreated Chronic Lymphocytic Leukemia (CLL): Pooled Analyses of Two Clinical Trials
2023 · Keshu Zhou, Mingyuan Sun, et al. · Blood · 15
Vitamin C-induced competitive binding of HIF-1α and p53 to ubiquitin E3 ligase CBL contributes to anti-breast cancer progression through p53 deacetylation
2022 · Yan Xiong, Shiyao Xu, et al. · Food and Chemical Toxicology · 14
Antitumor activity of sunvozertinib in NSCLC patients with EGFR Exon20 insertion mutations after platinum and anti-PD(L)1 treatment failures.
2022 · Pasi A. Janne, Mengzhao Wang, et al. · Journal of Clinical Oncology · 14
Identification of genetic variations associated with drug resistance in non-small cell lung cancer patients undergoing systemic treatment
2021 · Ruihan Luo, Chuang Ge, et al. · Briefings in Bioinformatics · 14
PDF
Works count: 63
Citation count: 1,304
H-index: 21
I10-index: 30
Year
Topic
Type